Results 161 to 170 of about 153,070 (268)

The role of actin cytoskeleton component Arp2/3 in inflammatory response. [PDF]

Front Cell Dev Biol
Xing J, Wang Y, Liang Y, Li J, Yao Y, Li J, Zhang K.   +6 more
europepmc   +1 more source

Targeting clathrin-mediated endocytosis: recent advances in inhibitor development, mechanistic insights, and therapeutic prospects. [PDF]

RSC Med Chem
Zhang C, Guo J, Liu Z, Huang X, Dong S, Hu C, Xiao J.   +6 more
europepmc   +1 more source

Comprehensive Transcriptomic Analysis of the Molecular Mechanisms Conferring Resistance to Rice Blast in the Elite Restorer Line Fuhui2165. [PDF]

Int J Mol Sci
Zhang S, Mao Y, Hong Y, Zheng F, Hu R, Tu S, Zhang F, Zhou P.   +7 more
europepmc   +1 more source

A tubulin-binding protein that preferentially binds to GDP-tubulin and promotes GTP exchange. [PDF]

J Biol Chem
Yon WJ, Ha T, Zheng Y, Pedersen RTA.
europepmc   +1 more source

The mechanism of thioamide formation by the YcfA-YcfC system in 6-thioguanine biosynthesis. [PDF]

Nat Commun
Zhang L, Dou C, Yan W, Chen P, Jia X, Zhang N, Zhou D, Long Z, Zhang L, Zhu X, Cheng W.   +10 more
europepmc   +1 more source

Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors. [PDF]

Cells
Tripathi M, Garbacki N, Willems J, Cobraiville G, Fillet M, Colige A, Deroanne CF.   +6 more
europepmc   +1 more source

Branched-chain amino acids in muscle growth: mechanisms, physiological functions, and applications. [PDF]

J Anim Sci Biotechnol
Xu S, Zhao G, Hanigan MD, Cantalapiedra-Hijar G, Li M.   +4 more
europepmc   +1 more source

Dynamic Executors of Bacterial Signals: Functional Versatility and Regulatory Networks of c-di-GMP Effectors. [PDF]

Biomolecules
Jia J, Yun G, Liu B, Li X, Jiang M, Yu X, Zhang J, Han Y, Liu D, Zhao J, Wang Y, Chen G.   +11 more
europepmc   +1 more source

Mechanisms and current advances in treating <i>KRAS</i>-mutated lung cancer. [PDF]

Chin Med J Pulm Crit Care Med
Chao CH, Di YP.
europepmc   +1 more source

Advances in biomarkers of resistance to KRAS mutation-targeted inhibitors. [PDF]

Discov Oncol
Wang L, Wei D, Li S, Jiang S.
europepmc   +1 more source